OTCMKTS:YBGJ Yubo International Biotech (YBGJ) Stock Price, News & Analysis $0.08 +0.02 (+25.82%) As of 05/28/2025 03:14 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsShort InterestBuy This Stock About Yubo International Biotech Stock (OTCMKTS:YBGJ) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get YBGJ alerts:Sign Up Key Stats Today's Range$0.05▼$0.0850-Day Range$0.04▼$0.0952-Week Range$0.03▼$1.37Volume2,622 shsAverage Volume11,218 shsMarket Capitalization$9.23 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewYubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.Read More… Yubo International Biotech Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks5th Percentile Overall ScoreYBGJ MarketRank™: Yubo International Biotech scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Yubo International Biotech. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Yubo International Biotech is -7.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Yubo International Biotech is -7.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of Yubo International Biotech has been sold short.Short Interest Ratio / Days to CoverYubo International Biotech has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Yubo International Biotech has recently increased by 200.00%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldYubo International Biotech does not currently pay a dividend.Dividend GrowthYubo International Biotech does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.00% of the float of Yubo International Biotech has been sold short.Short Interest Ratio / Days to CoverYubo International Biotech has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Yubo International Biotech has recently increased by 200.00%, indicating that investor sentiment is decreasing significantly. News and Social Media0.6 / 5News SentimentN/A News SentimentYubo International Biotech has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Yubo International Biotech this week, compared to 0 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Yubo International Biotech insiders have not sold or bought any company stock.Percentage Held by Insiders68.50% of the stock of Yubo International Biotech is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about Yubo International Biotech's insider trading history. Receive YBGJ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Yubo International Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address YBGJ Stock News HeadlinesYubo International Biotech Limited (YBGJ)March 21, 2025 | finance.yahoo.comYubo International Biotech LimitedNovember 21, 2024 | investing.comBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.May 29, 2025 | Crypto 101 Media (Ad)YBGJ Yubo International Biotech LimitedMay 25, 2024 | seekingalpha.comPromontory Therapeutics Selected as the First International Biotech Company Member of the Paris-Saclay Cancer ClusterOctober 1, 2023 | finance.yahoo.comYubo International Biotech Ltd.June 15, 2023 | wsj.comYubo International (OTC:YBGJ), Earnings Estimates, EPS, and RevenueJuly 18, 2022 | benzinga.comYubo International (OTC:YBGJ), Analyst Ratings, Price Targets, PredictionsJuly 18, 2022 | benzinga.comSee More Headlines YBGJ Stock Analysis - Frequently Asked Questions How have YBGJ shares performed this year? Yubo International Biotech's stock was trading at $0.0347 at the start of the year. Since then, YBGJ stock has increased by 121.9% and is now trading at $0.0770. View the best growth stocks for 2025 here. How do I buy shares of Yubo International Biotech? Shares of YBGJ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Yubo International Biotech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Yubo International Biotech investors own include AutoZone (AZO), Intel (INTC), TJX Companies (TJX), Abacus Health Products (ABAHF), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM) and Bank of America (BAC). Company Calendar Today5/28/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolOTCMKTS:YBGJ CIK895464 Webwww.yubogroup.com Phone(640) 677-6010Fax516-595-1159Employees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$1.20 million Net MarginsN/A Pretax Margin-8,254.97% Return on EquityN/A Return on Assets-121.41% Debt Debt-to-Equity RatioN/A Current Ratio0.16 Quick Ratio0.16 Sales & Book Value Annual Sales$610,000.00 Price / Sales12.01 Cash FlowN/A Price / Cash FlowN/A Book Value($0.02) per share Price / Book-3.06Miscellaneous Outstanding Shares119,821,000Free Float52,146,000Market Cap$7.33 million OptionableNot Optionable Beta4.17 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (OTCMKTS:YBGJ) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yubo International Biotech Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Yubo International Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.